A motion for preliminary approval of a class action settlement between Deloitte and the victims of the RIBridges data breach ...

Condensate formation is central to how budding yeast cells decide their response to environmental and internal conditions ...

A new study reveals that men with a mutation to the BRCA genes, often known as the ‘Angelina Jolie’ gene because the ...

Endocrine therapy typically slows cell cycle progression by reducing cyclin D1, which partners with CDK4/6 to promote cell ...

Australia could be a global hub for food tech and biomanufacturing, but only if the government backs the industry through ...

The escape of 75,000 farmed fish from damaged pens in the Highlands could pose a genetic threat to native Atlantic salmon.

Record-breaking participation as 6,800 tech enterprises, 2,000 startups, 1,200 investors, and tech representatives from 180 ...

A poster titled Updated data from ABOYA-119: A phase 1/2a trial of ATRN-119, a novel macrocyclic ATR inhibitor, in patients with advanced solid tumors harboring DNA damage will be presented at the ...

About Aprea Aprea’s mission is to develop novel cancer therapies that target cancer cells directly, while sparing healthy ones. By exploiting unique vulnerabilities in cancer cell mutations, this ...

Developers work with the NHS, the medicines regulator and the UK health technology assessment bodies from the early stages of clinical development, as ...